Report of health checkup system for chronic kidney disease in general population in Okayama city: effect of health guidance intervention on chronic kidney disease outcome.
health consciousness
life style
prevention medicine
renal function
Journal
International journal of nephrology and renovascular disease
ISSN: 1178-7058
Titre abrégé: Int J Nephrol Renovasc Dis
Pays: New Zealand
ID NLM: 101550217
Informations de publication
Date de publication:
2019
2019
Historique:
received:
19
12
2018
accepted:
22
05
2019
entrez:
17
7
2019
pubmed:
17
7
2019
medline:
17
7
2019
Statut:
epublish
Résumé
From 2011, Okayama municipal government started the health checkup follow-up project to find those who were unaware of suffering chronic kidney disease and to prevent from aggravation of CKD stage. In this study, we aimed to evaluate the effect of 2 years' CKD-follow-up project regarding renal function and CKD risks. Those who received a health checkup by the national health insurance in Okayama city in 2011 were recruited. The patients with lifestyle-related diseases or metabolic syndrome were excluded. Subjects who had an estimated glomerular filtration rate<50 mL/min/1.73 m A total of 28,309 people received a health checkup in 2011. In compromised renal function group, 39.5% (96/243) of the subjects improved their CKD stages in 2013 regardless of the visit of medical institutions or the frequency of receiving health checkup. In risk group, 63.4% (260/410) of the subjects decreased their CKD risks in 2013 independent of the reception of health guidance. In both compromised renal function group and risk group, more than half of subjects kept their kidney function (217/243) and decreased the number of CKD risks (260/410) in 2 years' follow-up. Receiving a health checkup itself and notification of one's own health condition could exert a protective effect on kidney function.
Sections du résumé
BACKGROUND
BACKGROUND
From 2011, Okayama municipal government started the health checkup follow-up project to find those who were unaware of suffering chronic kidney disease and to prevent from aggravation of CKD stage. In this study, we aimed to evaluate the effect of 2 years' CKD-follow-up project regarding renal function and CKD risks.
PATIENTS AND METHODS
METHODS
Those who received a health checkup by the national health insurance in Okayama city in 2011 were recruited. The patients with lifestyle-related diseases or metabolic syndrome were excluded. Subjects who had an estimated glomerular filtration rate<50 mL/min/1.73 m
RESULTS
RESULTS
A total of 28,309 people received a health checkup in 2011. In compromised renal function group, 39.5% (96/243) of the subjects improved their CKD stages in 2013 regardless of the visit of medical institutions or the frequency of receiving health checkup. In risk group, 63.4% (260/410) of the subjects decreased their CKD risks in 2013 independent of the reception of health guidance.
CONCLUSION
CONCLUSIONS
In both compromised renal function group and risk group, more than half of subjects kept their kidney function (217/243) and decreased the number of CKD risks (260/410) in 2 years' follow-up. Receiving a health checkup itself and notification of one's own health condition could exert a protective effect on kidney function.
Identifiants
pubmed: 31308723
doi: 10.2147/IJNRD.S198781
pii: 198781
pmc: PMC6612981
doi:
Types de publication
Journal Article
Langues
eng
Pagination
143-152Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Adv Chronic Kidney Dis. 2007 Jan;14(1):105-12
pubmed: 17200050
Am Heart J. 1984 Nov;108(5):1347-52
pubmed: 6496291
J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S37-40
pubmed: 11792760
J Am Soc Nephrol. 2007 Apr;18(4):1307-15
pubmed: 17344421
J Am Soc Nephrol. 2006 Oct;17(10):2928-36
pubmed: 16959828
Am J Kidney Dis. 2005 Sep;46(3):406-14
pubmed: 16129201
Clin Exp Nephrol. 2009 Dec;13(6):621-30
pubmed: 19513802
Lancet. 2012 Jan 14;379(9811):165-80
pubmed: 21840587
Am J Kidney Dis. 2005 Nov;46(5):863-70
pubmed: 16253726
Hypertens Res. 2008 Mar;31(3):433-41
pubmed: 18497462
Circulation. 2003 Oct 28;108(17):2154-69
pubmed: 14581387
Nihon Jinzo Gakkai Shi. 2012;54(8):1034-191
pubmed: 23387281
Lancet. 2010 Jun 12;375(9731):2073-81
pubmed: 20483451
Kidney Int. 2017 Jan;91(1):227-234
pubmed: 27884399
BMJ. 1990 Feb 3;300(6720):297-300
pubmed: 2106959
N Engl J Med. 2004 Sep 23;351(13):1296-305
pubmed: 15385656
Ann Intern Med. 2003 Dec 2;139(11):901-6
pubmed: 14644892
Arch Intern Med. 2004 Mar 22;164(6):659-63
pubmed: 15037495
Kidney Int. 2013 Sep;84(3):622-3
pubmed: 23989362
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
pubmed: 11904577
Kidney Int. 2011 Jul;80(1):17-28
pubmed: 21150873
Ther Apher Dial. 2014 Dec;18(6):535-602
pubmed: 25523509